Table 1. Prevalence of antimicrobial use, by country, 23 European Union/European Economic Area countriesa, the former Yugoslav Republic of Macedonia and Serbia, 2016–2017.
| Country | LTCFs | Eligible residents | Antimicrobial use | |||
|---|---|---|---|---|---|---|
| Residents with at least one antimicrobial | Observed prevalence | Mean prevalence of LTCFs | Median prevalence of LTCFs | |||
| n | n | n | % (95% CI) | % | IQR (%) | |
| Austria | 12 | 2,065 | 67 | 3.2 (2.5 to 4.1) | 2.9 | 2.4 (1.0 to 4.7) |
| Belgium | 79 | 8,206 | 482 | 5.9 (5.4 to 6.4) | 5.8 | 5.1 (2.9 to 8.1) |
| Croatia | 8 | 1,607 | 32 | 2.0 (1.4 to 2.8) | 3.2 | 3.6 (0.8 to 4.9) |
| Cyprus | 11 | 312 | 29 | 9.3 (6.3 to 13.1) | 10.1 | 7.7 (4.8 to 17.0) |
| Denmark | 95 | 3,346 | 350 | 10.5 (9.4 to 11.5) | 10.7 | 9.0 (6.3 to 15.0) |
| Finland | 149 | 5,914 | 394 | 6.7 (6.0 to 7.3) | 7.0 | 5.9 (2.3 to 10.5) |
| France | 91 | 6,957 | 187 | 2.7 (2.3 to 3.1) | 2.7 | 2.3 (0 to 4.3) |
| Germany | 82 | 6,705 | 85 | 1.3 (1.0 to 1.6) | 1.3 | 0.9 (0 to 1.9) |
| Greece | 13 | 812 | 49 | 6.0 (4.5 to 7.9) | 7.5 | 4.2 (3.0 to 11.6) |
| Hungary | 75 | 7,670 | 71 | 0.9 (0.7 to 1.2) | 0.9 | 0 (0 to 1.4) |
| Ireland | 109 | 5,613 | 543 | 9.7 (8.9 to 10.5) | 11.7 | 8.6 (5.4 to 14.7) |
| Italy | 196 | 11,417 | 495 | 4.3 (4.0 to 4.7) | 5.5 | 3.1 (0.8 to 6.6) |
| Lithuania | 26 | 3,438 | 25 | 0.7 (0.5 to 1.1) | 0.9 | 0 (0 to 1.0) |
| Luxembourg | 16 | 1,616 | 42 | 2.6 (1.9 to 3.5) | 2.5 | 1.5 (0.9 to 4.2) |
| Malta | 11 | 2,485 | 66 | 2.7 (2.1 to 3.4) | 1.6 | 1.4 (0.5 to 2.4) |
| The Netherlands | 57 | 4,547 | 202 | 4.4 (3.9 to 5.1) | 5.1 | 4.3 (1.6 to 6.7) |
| Norway | 62 | 2,447 | 169 | 6.9 (5.9 to 8.0) | 7.0 | 4.6 (2.1 to 10.3) |
| Poland | 24 | 2,281 | 73 | 3.2 (2.5 to 4.0) | 4.4 | 2.9 (0.9 to 6.5) |
| Portugal | 132 | 3,633 | 220 | 6.1 (5.3 to 6.9) | 6.8 | 4.3 (0 to 10.0) |
| Slovakia | 59 | 5,091 | 113 | 2.2 (1.8 to 2.7) | 2.9 | 1.2 (0 to 3.4) |
| Spain | 46 | 6,808 | 717 | 10.5 (9.8 to 11.3) | 11.7 | 10.8 (3.5 to 17.3) |
| Sweden | 285 | 3,604 | 118 | 3.3 (2.7 to 3.9) | 3.2 | 0 (0 to 5.6) |
| UK – Northern Ireland | 70 | 2,614 | 270 | 10.3 (9.2 to 11.6) | 10.4 | 9.8 (5.0 to 14.3) |
| UK – Scotland | 52 | 2,147 | 138 | 6.4 (5.4 to 7.5) | 6.2 | 5.1 (0 to 10.9) |
| UK – Wales | 28 | 966 | 98 | 10.1 (8.3 to 12.2) | 10.1 | 8.2 (5.5 to 11.4) |
| EU/EEA | 1,788 | 102,301 | 5,035 | 4.9 (4.8 to 5.1) | 5.8 | 3.6 (0 to 8.5) |
| former Yugoslav Republic of Macedonia | 4 | 294 | 26 | 8.8 (5.9 to 12.7) | 5.2 | 5.1 (2.5 to 7.9) |
| Serbia | 6 | 1,168 | 57 | 4.9 (3.7 to 6.3) | 6.0 | 4.0 (3.7 to 5.5) |
CI: confidence interval; EU/EEA: European Union/European Economic Area; IQR: interquartile range; LTCFs: long-term care facilities; UK: United Kingdom.
aFor the United Kingdom, data for Northern Ireland, Scotland and Wales are presented separately. England did not participate in the survey. The Czech Republic did not provide resident-level data.